^
Association details:
| Biomarker: | CSF3R M696T |
|---|---|
| Cancer: | Acute Lymphocytic Leukemia |
| Drug Class: | Tyrosine kinase inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
The Colony-Stimulating Factor 3 Receptor M696T Mutated in a Patient with Ph+ Acute Lymphoblastic Leukemia
Published date:
11/04/2020
Excerpt:
This patient achieved complete remission with chemotherapy in combination with tyrosine kinase inhibitor (TKI) and long-term survival by unrelated donor transplantation. We confirmed the presence of a CSF3R M696T germline mutation in this patient, and the mutation was inherited from her mother.
DOI:
https://doi.org/10.1182/blood-2020-133772
